Who Owns AIM ImmunoTech Stock?
NYSE: AIMHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
Market open · Delayed 15 min · as of Oct 9, 11:47 AM ET
Ownership breakdown
- Held by institutions
- 2.88%
- Held by insiders
- 0.51%
- Institutional holders
- 19
- Institutions 2.9%
- Insiders 0.5%
- Public and other 96.6%
Who owns AIM ImmunoTech stock?
Institutional investors own about 2.9% of AIM ImmunoTech's shares, spread across 19 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 0.51% of AIM.
The largest institutional holders are Jane Street Group, LLC (1.06%), Virtu Financial LLC (0.16%) and Morgan Stanley (0.07%). Together, the top 10 institutions control 1.5% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their AIM positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of AIM
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Jane Street Group, LLC | 807.88K | 1.06% | +3929.9% |
| Virtu Financial LLC | 124.27K | 0.16% | +144.2% |
| Morgan Stanley | 50.86K | 0.07% | +5787.0% |
| Geode Capital Management, LLC | 46.00K | 0.06% | +53.8% |
| Goldman Sachs Group Inc | 32.44K | 0.04% | +100.0% |
| UBS Group AG | 28.93K | 0.04% | +2893000.0% |
| Susquehanna International Group, LLP | 21.86K | 0.03% | +100.0% |
| Vanguard Fiduciary Trust Co | 17.52K | 0.02% | 0.0% |
| Ground Swell Capital, LLC | 12.22K | 0.02% | +100.0% |
| Tower Research Capital LLC (TRC) | 4.67K | 0.01% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of AIM
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 44.08K | 0.06% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 682 | 0.00% |
Frequently asked questions
Who is the largest shareholder of AIM ImmunoTech?
Jane Street Group, LLC is the largest institutional shareholder of AIM, owning 1.06% of shares outstanding (807.88K shares) as of its latest 13F filing.
What percentage of AIM ImmunoTech is owned by institutions?
Institutions own about 2.9% of AIM shares and 2.9% of the public float.
How much of AIM ImmunoTech do insiders own?
Insiders, such as officers and directors, own about 0.51% of AIM shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.